Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.94 +0.07 (+1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Net Equity Issued and Repurchased (2021 - 2026)

Updated

Unicycive Therapeutics (UNCY) recorded Net Equity Issued and Repurchased of $1.5 million in FY2025.

Analysis

Unicycive Therapeutics (UNCY) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

  • Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of -49.1% (FY2021 to FY2025).
  • The FY2025 figure is the highest annual Net Equity Issued and Repurchased since FY2021.
  • Per Business Quant data, UNCY's Net Equity Issued and Repurchased was $11,000 in FY2022 (-100.0%) and $22.27 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -346.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Unicycive Therapeutics 109.75 Mn -90.23 Mn - 14.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.89 Mn
Mar 31, 2026 20.17 Mn
Dec 31, 2025 6.81 Mn
Sep 30, 2025 27.15 Mn
Jun 30, 2025 11.33 Mn
Mar 31, 2025 2.79 Mn
Mar 31, 2023 30.19 Mn
Sep 30, 2021 22.27 Mn
Mar 31, 2021 119,000.00
API Access

Unicycive Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=UNCY&period=max&api_key=YOUR_API_KEY